TRCT
CLPT icon

Tower Research Capital (TRC)’s ClearPoint Neuro CLPT Stock Holding History

Tower Research Capital (TRC)’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27K Sell
2,969
-227
-7% -$2.87K ﹤0.01% 3264
2025
Q4 		$43.7K Buy
3,196
+686
+27% +$12.7K ﹤0.01% 2524
2025
Q3 		$54.7K Buy
2,510
+1,601
+176% +$18.9K ﹤0.01% 2456
2025
Q2 		$10.9K Sell
909
-6,827
-88% -$85.9K ﹤0.01% 3931
2025
Q1 		$92K Buy
7,736
+1,684
+28% +$26.2K ﹤0.01% 1818
2024
Q4 		$93.1K Buy
+6,052
New +$78.4K ﹤0.01% 2181
2024
Q3 		– Sell
-10,681
Closed -$57.6K – 5735
2024
Q2 		$57.6K Buy
10,681
+9,107
+579% +$52.7K ﹤0.01% 2993
2024
Q1 		$10.7K Sell
1,574
-544
-26% -$3.8K ﹤0.01% 3663
2023
Q4 		$14.4K Sell
2,118
-198
-9% -$1.12K ﹤0.01% 3890
2023
Q3 		$11.6K Buy
2,316
+117
+5% +$696 ﹤0.01% 3972
2023
Q2 		$15.9K Sell
2,199
-224
-9% -$1.91K ﹤0.01% 3598
2023
Q1 		$21K Buy
2,423
+1,717
+243% +$15K ﹤0.01% 3374
2022
Q4 		$6K Sell
706
-7,788
-92% -$73.8K ﹤0.01% 4693
2022
Q3 		$88K Buy
+8,494
New +$112K ﹤0.01% 2669
2022
Q2 		– Sell
-1,073
Closed -$11K – 6113
2022
Q1 		$11K Sell
1,073
-7,705
-88% -$70.1K ﹤0.01% 4154
2021
Q4 		$98K Buy
8,778
+8,069
+1,138% +$121K ﹤0.01% 2228
2021
Q3 		$12K Buy
709
+450
+174% +$8.44K ﹤0.01% 4136
2021
Q2 		$5K Sell
259
-968
-79% -$18.7K ﹤0.01% 4693
2021
Q1 		$26K Buy
1,227
+598
+95% +$12.8K ﹤0.01% 3671
2020
Q4 		$10K Buy
629
+35
+6% +$314 ﹤0.01% 4303
2020
Q3 		$3K Buy
594
+487
+455% +$2.15K ﹤0.01% 4483
2020
Q2 		$0 Buy
+107
New +$398 ﹤0.01% 4758

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Tower Research Capital (TRC)'s CLPT Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its ClearPoint Neuro (CLPT) stake by 7.1% in Q1 2026, selling an estimated $2.87K and leaving 2,969 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #3264.

Tower Research Capital (TRC) first reported a position in CLPT in Q2 2020 and has held it in 22 quarters since. The position peaked at $98K in Q4 2021. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Tower Research Capital (TRC) held 2,969 shares of ClearPoint Neuro worth $27K as of Q1 2026.
  • Tower Research Capital (TRC) sold 227 ClearPoint Neuro shares in Q1 2026, an estimated $2.87K.
  • ClearPoint Neuro made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3264 holding.
  • Tower Research Capital (TRC) first reported a position in ClearPoint Neuro in Q2 2020 and has held it in 22 quarters since.
  • Tower Research Capital (TRC)'s ClearPoint Neuro position peaked at $98K in Q4 2021.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.